Bgm (BGM) Non-Current Deffered Revenue (2019 - 2026)
Bgm's Non-Current Deffered Revenue came in at $207,809 for fiscal Q2 2026 (quarter ended Mar 31, 2026), down 12.6% from $237,869 a year earlier.
Powered by 
Analysis
Bgm (BGM) Non-Current Deffered Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Bgm's Non-Current Deffered Revenue was $240,154, up 78.7% from FY2024.
- Non-Current Deffered Revenue carries a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
- Going back by fiscal year, Non-Current Deffered Revenue was $134,394 in FY2024 (-39.4%), $221,879 in FY2023 (-28.4%), $309,943 in FY2022 (-23.2%) and $403,745 in FY2021 (-44.1%).
- The fiscal Q2 2026 figure represents the lowest quarterly Non-Current Deffered Revenue since fiscal Q4 2024.
- Year-over-year, Non-Current Deffered Revenue increased in two of the last four quarters, with growth averaging 13.9%.
- The fastest year-over-year change in Non-Current Deffered Revenue over five years came in fiscal Q4 2025 (growth of 78.7%), and the weakest in fiscal Q4 2021 (a decline of 44.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Bgm | 28.32 Mn | -4,800.01 Bn | - | 207,809.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 207,809.00 |
| Sep 30, 2025 | 240,154.00 |
| Mar 31, 2025 | 237,869.00 |
| Sep 30, 2024 | 134,394.00 |
| Mar 31, 2024 | 184,328.00 |
| Sep 30, 2023 | 221,879.00 |
| Mar 31, 2023 | 267,551.00 |
| Sep 30, 2022 | 309,943.00 |
| Mar 31, 2022 | 386,344.00 |
| Sep 30, 2021 | 403,745.00 |
| Sep 30, 2020 | 722,137.00 |
| Sep 30, 2019 | 972,338.00 |
API Access
Bgm Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BGM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "BGM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=BGM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();